Nationwide Children's Hospital contracts with GenomeNext for genomic analysis

Staff - Print  | 

Nationwide Children's Hospital in Columbus, Ohio, will incorporate GenomeNext's genomic analysis platform for clinical research initiatives and laboratory services.

GenomeNext, also headquartered in Columbus, Ohio, will provide analysis on a cloud-based, software-as-a-service platform to the hospital for faster genomic analysis in a laboratory setting. The company claims to be able to sequence a genome in less than 3 hours. It bought the license for a high-speed mass genome processor developed by researchers at Nationwide Children's Hospital. GenomeNext signed the license deal for the system, called Churchill, in January.

Genomic analysis in pediatrics is usually used for the analysis of cancers and other hard-to-diagnose diseases.

"While genome sequencing is quickly becoming a commodity, it is the ability to creatively and accurately analyze the terabytes of data that come from genome sequencing that is so very important in pediatric medicine today," John Barnard, MD, president of the Research Institute at Nationwide Children's Hospital, said in a news release. "With the right resources and being at the forefront of available technologies, we are uniquely positioned to affect positive change in pediatric health with best outcomes for every child in mind."

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.